PAPER Novak M, Jakes R, Edwards PC, Milstein C, Wischik CM
SEARCH RESULTS
331159 RESULTS
PAPER Goedert M, Spillantini MG, Cairns NJ, Crowther RA
Tau proteins of Alzheimer paired helical filaments: abnormal phosphorylation of all six brain isoforms.
Neuron. 1992 Jan;8(1):159-68. PubMed: 1530909PAPER Delacourte A, Flament S, Dibe EM, Hublau P, Sablonnière B, Hémon B, Shérrer V, Défossez A
Pathological proteins Tau 64 and 69 are specifically expressed in the somatodendritic domain of the degenerating cortical neurons during Alzheimer's disease. Demonstration with a panel of antibodies against Tau proteins.
Acta Neuropathol. 1990;80(2):111-7. PubMed: 2117840Does TauRx Drug Work by Oxidizing Tau?
RESEARCH NEWS 2013-02-21 Research News In 2008, Rember ™, aka methylene blue, created a stir when the drug’s sponsors reported that it slowed cognitive decline in a Phase 2 trial for Alzheimer’s disease, while other scientists questioned that interpretation (see ARF related news
PAPER Fernández E, García-Moreno JM, Pablos AM, Chacón J
May the Evaluation of Nitrosative Stress Through Selective Increase of 3-Nitrotyrosine Proteins Other Than Nitroalbumin and Dominant Tyrosine-125/136 Nitrosylation of Serum α-Synuclein Serve for Diagnosis of Sporadic Parkinson's Disease?
Antioxid Redox Signal. 2013 Mar 28; PubMed: 23418747PAPER Yeh HH, Young D, Gelovani JG, Robinson A, Davidson Y, Herholz K, Mann DM
Histone deacetylase class II and acetylated core histone immunohistochemistry in human brains with Huntington's disease.
Brain Res. 2013 Apr 4;1504:16-24. PubMed: 23419892PAPER Milanesi E, Bonvicini C, Alberici A, Pilotto A, Cattane N, Premi E, Gazzina S, Archetti S, Gasparotti R, Cancelli V, Gennarelli M, Padovani A, Borroni B
Molecular signature of disease onset in Granulin mutation carriers: a gene expression analysis study.
Neurobiol Aging. 2013 Jul;34(7):1837-45. PubMed: 23419701PAPER Maniwang E, Tayebi N, Sidransky E
Is Parkinson disease associated with lysosomal integral membrane protein type-2?: challenges in interpreting association data.
Mol Genet Metab. 2013 Apr;108(4):269-71. PubMed: 23419877PAPER Parnetti L, Castrioto A, Chiasserini D, Persichetti E, Tambasco N, El-Agnaf O, Calabresi P
Cerebrospinal fluid biomarkers in Parkinson disease.
Nat Rev Neurol. 2013 Mar;9(3):131-40. PubMed: 23419373PAPER Chan FT, Kaminski Schierle GS, Kumita JR, Bertoncini CW, Dobson CM, Kaminski CF
Protein amyloids develop an intrinsic fluorescence signature during aggregation.
Analyst. 2013 Apr 7;138(7):2156-62. PubMed: 23420088PAPER Darawi MN, Ai-Vyrn C, Ramasamy K, Hua PP, Pin TM, Kamaruzzaman SB, Majeed AB
Allele-specific polymerase chain reaction for the detection of Alzheimer's disease-related single nucleotide polymorphisms.
BMC Med Genet. 2013;14:27. PubMed: 23419238PAPER Sinha N, Grimes D, Tokuhiro S, Sato C, Rogaeva E, Woulfe J
Variant Alzheimer's disease with spastic paraparesis and supranuclear gaze palsy.
Can J Neurol Sci. 2013 Mar;40(2):249-51. PubMed: 23419577PAPER Cheng D, Logge W, Low JK, Garner B, Karl T
Novel behavioural characteristics of the APP(Swe)/PS1ΔE9 transgenic mouse model of Alzheimer's disease.
Behav Brain Res. 2013 May 15;245:120-7. PubMed: 23419740PAPER Gray SL, Anderson ML, Hubbard RA, Lacroix A, Crane PK, McCormick W, Bowen JD, McCurry SM, Larson EB
Frailty and Incident Dementia.
J Gerontol A Biol Sci Med Sci. 2013 Feb 18; PubMed: 23419778PAPER Andreasson U, Lautner R, Schott JM, Mattsson N, Hansson O, Herukka SK, Helisalmi S, Ewers M, Hampel H, Wallin A, Minthon L, Hardy J, Blennow K, Zetterberg H
CSF biomarkers for Alzheimer's pathology and the effect size of APOE ɛ4.
Mol Psychiatry. 2013 Feb 19; PubMed: 23419830Current Filters
No filters selected